Relapse Rectory Large Olemboma - Is There a Clinical Trial?

I have seen patients drive benefit from the drug in the post-car T cell setting. Has it been miraculous CRs? Not necessarily, but disease stability that may get them the time that the bone marrow needs to recover after CAR T cells. I think we've seen some data to that effect and that's unfortunate, you know, but that's just reality.